Laboratorios Farmaceuticos Rovi SA (fra:41L) Share Price

Company Profile

Business description
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
Contact
Julian Camarillo, 35
Madrid28037
ESP
T: +34 913756230
E: [email protected]
https://www.rovi.es
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
2,188

Recommended

AI is reshaping ASX tech moats - but some are more insulated than others.

Tyger Fitzpatrick | 22 March 2026

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.

Dan Romanoff, CPA | 20 March 2026

Sims guides huge earnings upgrade as data center metals demand spikes.

Esther Holloway | 20 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,552.60	77.00	0.91%
CAC 40	7,748.00	82.38	1.07%
DAX 40	22,724.37	344.18	1.54%
Dow JONES (US)	45,577.47	443.96	-0.96%
FTSE 100	9,922.79	4.46	0.04%
HKSE	24,382.47	894.85	-3.54%
NASDAQ	21,647.61	443.08	-2.01%
Nikkei 225	51,515.49	1,857.04	-3.48%
NZX 50 Index	12,899.72	90.27	-0.69%
S&P 500	6,506.48	100.01	-1.51%
S&P/ASX 200	8,365.90	82.40	0.99%
SSE Composite Index	3,813.28	143.77	-3.63%